Namibia, 1994
Gonorrhea
Chlamydia
Trichomonas
Candida
Bacterial
Vaginosis
Syphilis
HIV
Slide 1
Chancroid
Syphilis
Herpes
LGV
Chancroid & syphilis
Chancroid & Herpes
Chancroid & syphilis & Herpes
+/1 LGV
Syphilis & LGV
Syphilis & Herpes
Unknown
HIV
Slide 2
STI Management
Syndromic management
Presumptive treatment of the most
likely diagnoses
Addresses high rate of co-infections
Avoids unnecessary screening tests
Slide 3
Topics Covered in
this Unit
Genital ulcers
Syphilis
Inguinal buboes
Male urethral discharge
Scrotal swelling
Female vaginal discharge
Lower abdominal pain and
Pelvic Inflammatory Disease
Men who have sex with men
Counselling about safer sex
Unit 3: Sexually Transmitted Infections (STIs)
Slide 4
Genital Ulcer
Disease (GUD)
Each ulcer-causing condition has
typical features, but patients often
present with atypical features or
multiple simultaneous conditions.
Without rigorous laboratory
testing, we cannot be certain of
the etiology.
Syndromic management is
directed at the most common
curable conditions.
Slide 5
Non-infectious
Syphilis*
Chancroid*
Lymphogranuloma
venereum
Granuloma
inguinale
Herpes simplex*
Pyoderma
Cutaneous amoeba
Trauma
Fixed drug
eruption
Erythema
multiforme
Squamous cell
cancer
Autoimmune
ulcers
Bechets
syndrome
Reiters
syndrome
STIs in red
Slide 6
Treatment of Genital
Ulcers
Primary Syphilis (Treponema
pallidum)
Slide 7
Genital Ulcer
No
Blisters and
recurrent
blisters
Genital ulcer
Penicillin IM
Ceftriaxone IM
Health Ed
Partner Treatment
Condoms
HIV testing
Yes
Multiple blisters
Clean lesions
Health Ed
Condoms
HIV testing
Secondary infection:
Cotrimoxazole
No improvement?
Reinfection?
No
Refer
Re-evaluate
Yes
Treat partner
Repeat protocol
Frenulum
Source: Wellcome Trust, 2003
Coronal sulcus
Also shaft and
inner side of
prepuce
(foreskin)
Source: Wellcome Trust, 2003
Unit 3: Sexually Transmitted Infections (STIs)
Corona
Slide 9
Primary Syphilis in
Women
Primary syphilis is often
asymptomatic in women
The most common sites of
chancres are the labia,
fourchette, and cervix.
Labia
Unit 3: Sexually Transmitted Infections (STIs)
Slide 10
Uncommon Locations
of Chancres
Slide 11
Slide 12
Secondary Syphilis
Signs and Symptoms
Rash: often on palms and
soles of feet, trunk
Malaise
Generalized lymphadenopathy
Mucous patches (oral cavity,
pharynx, larynx, genitals)
Condylomata lata
Alopecia
Neurosyphilis
Slide 13
Rash of Secondary
Syphilis in a Pregnant
Woman
Source: Wellcome Trust, 2003
Slide 14
Condylomata Lata:
Mucosal Lesions of
Secondary Syphilis
Slide 15
Syphilis
Signs and Symptoms
Latent
No clinical manifestations
Only evidence is positive
serologic test
Early Latent
<1 year duration
Late Latent
>1 year duration or unknown
Slide 16
Neurosyphilis
Symptomatic neurosyphilis
may present as:
Lymphocytic meningitis
Stroke syndromes
Seizure disorders
Progressive dementia
Psychosis
Spinal cord dysfunction (tabes
dorsalis)
Slide 17
Tertiary Syphilis
Some untreated patients
develop other effects of
syphilis 15-25 years or more
after infection
Benign tertiary syphilis
(gummas): liver masses, skin
disorders, eye lesions, bone
deterioration (6%)
Syphilis of the heart and great
vessels (4%).
Slide 18
Serologic Diagnosis
of Syphilis
Non-Treponemal Antibody:
3 names, same test
RPR (rapid plasma reagen)
VDRL (venereal disease research
laboratory)
WR (Wasserman reaction)
Detects the immune reaction, but not an
antibody test
RPR may be negative in primary
syphilis
Titre is high in secondary disease and
drops over time and after treatment
Antibody Test: Treponema Pallidum
Haemagglutination (THPA)
Done to confirm RPR (+) tests
Slide 19
Diagnosis of
Neurosyphilis
Positive serum RPR or
treponemal antibody test
Abnormal CSF
increased WBC
increased protein
positive CSF VDRL (not RPR)
Many false-negative tests occur
Slide 20
Syphilis
Treatment
Primary, secondary, early
latent:
Benzathine penicillin 2.4 million
units IM once
Neurosyphilis
Penicillin G 2-4 million units IV
q4 hourly for 10-14 days
Slide 21
Slide 22
Chancroid in Men
Painful
Soft edge
Clean, sharp
edges
Yellow exudate
in base
Source: Wellcome Trust, 2003
May be multiple
Most common
locations:
foreskin,
corona,
frenulum
Source: Wellcome Trust, 2003
Unit 3: Sexually Transmitted Infections (STIs)
Slide 23
Chancroid in Women
Painful
Soft edges
Clean, sharp
edges
Yellow
exudate in
base
May be
multiple
Most common
locations:
Labia,
fourchette,
clitoris,
introitus
Slide 24
Slide 25
Slide 26
Painful GUD:
Differential
Clustered painful vesicles and
ulcers are typical of Herpes
Simplex Virus (HSV)
Recurrent clustered painful
vesicles very typical of HSV
Other painful genital ulcers:
Chancroid: can be multiple
especially with HIV co-infection
Bacterial super-infection of any
other genital ulcer
Slide 27
Treatment of HSV
Slide 28
Slide 29
Painful Ulcers:
Chancroid or HSV?
Slide 30
Painful Ulcers:
Chancroid or HSV?
Chancroid: multiple ulcers on
foreskin with edema.
Oval, well defined, granular base,
yellow exudate
Slide 31
Other Causes of
Genital Ulcers
Slide 32
Lymphogranuloma
venereum (C. trachomatis
L1, L2 or L3)
Starts as papule
May cause painless ulcer
Papule/ulcer often
unapparent and heals
spontaneously
Cause inguinal
lymphadenopathy and
buboes
Treatment 14 days doxycline
or erythromicin
Slide 33
Granuloma Inguinale
Caused by
Calymmatobacterium
granulomatis
Uncommon
Large chronic
ulcers
Painless
Beefy red
Bleed easily
Treatment
21 days of
Source: Wellcome Trust, 2003
Doxycycline 100 mg bd
OR
Erythromycin 500 mg 4x day
Slide 34
Inguinal Bubo
No
Genital
Ulcer
present?
Doxycycline 100 mg bd
14 days
Health ed/Partner
treatment
HIV/RPR test
Aspirate bubo if needed
Condoms
Pregnancy: erythromycin
500 mg qid 14 days
Improvement in 7 days?
No
Yes
Yes
Fluctuance?
Continue treatment
Continue treatment
No
Yes
Aspirate bubo
Continue treatment
Unit 3: Sexually Transmitted Infections (STIs)
Slide 36
Inguinal Adenopathy:
Differential Diagnosis
Chancroid
Lymphogranuloma venereum
Leg infections
Hernia
Inguinal or femoral
Cancer
Slide 37
Aspirate
bubo if
needed.
HIV and
RPR tests.
Source: Wellcome Trust, 2003
Unit 3: Sexually Transmitted Infections (STIs)
Slide 38
Lymphogranuloma
venereum
Aspirate
bubo if
needed.
HIV and
RPR tests.
Source: Wellcome Trust, 2003
Slide 39
Male Urethral
Discharge
Re-infection?
Repeat Protocol
Treat Partner
Poor adherence?
Neither?
Extend doxycycline
to 10 days
Refer
Symptoms persist?
Unit 3: Sexually Transmitted Infections (STIs)
Slide 40
Male Urethral
Discharge (2)
Gonorrhea
Neisseria
gonorrhea
Non-Gonococcal
Urethritis (NGU)
Chlamydia
trachomatis
Mycoplasma
genitalis
Ureaplasma
urealiticum
Others
Slide 41
Male Urethral
Discharge (3)
Ciprofloxacin 500 mg po stat
Treats gonorrhea
Health education
Partner treatment
Condoms
HIV and RPR testing
Slide 42
Scrotal Swelling
Acute onset of pain
and / or swelling?
History of trauma?
Refer urgently
Continue
treatment
Improved in 5 days?
Refer
Slide 43
Scrotal Swelling:
differential diagnosis
Acute Epididymo-orchitis
May have urethritis, also
Chronic Epididymo-orchitis
Testicular torsion
Acute severe pain, elevating
testes may greatly reduce pain
Trauma
history
Hernia
Swelling originates in inguinal
ring, bowel sounds?, reducible?
Unit 3: Sexually Transmitted Infections (STIs)
Slide 44
Scrotal Swelling:
differential diagnosis (2)
Acute Epididymo-orchitis < 35
years old
Neisseria gonorrhoea
Chlamydia trachomatis
Chronic Epididymo-orchitis
Tuberculosis
Slide 45
Treatment of
Epididymo-Orchitis
Ciprofloxacin 500 mg po stat
Docycycline 100 mg po bd for
10 days
Health education
Partner treatment
Condoms
HIV test
RPR test
Slide 46
Vaginal Discharge
Yes
Re-infection?
Repeat Protocol
Treat Partner
Return if symptoms
persist
Return if symptoms
persist
Poor adherence
Good adherence
Repeat
Doxycycline
7 days
Clotrimazole
pessary 500 mg
stat
Symptoms persist
Refer
Slide 47
Cervicitis
Urethritis
Candida
GC*
GC*
Bacterial
vaginosis
Chlamydia*
Chlamydia
(NGU)*
Trichomonas* Trichomonas*
(HSV*)
(Syphilis*)
Slide 48
Treatment of Vaginal
Discharge
Low Risk Women:
Treat for vaginitis
Candidiasis
Bacterial vaginosis
Slide 49
Vulvovaginal Candidiasis
Slide 50
Metronidazole
400 mg bd x 7 days most
effective
400 mg 5 tabs once (same as
Trichomoniasis therapy)
Slide 51
Treatment of Women
at risk for STD
All women with
Age < 25 years
Sexual partner with STD
symptoms
New sexual partner in last 3
months
Sexual partner had other
partners in last 3 months
Slide 52
Trichomoniasis
Metronidazole
400 mg 5 tabs once
OR
400 mg bd x 7 days
Unit 3: Sexually Transmitted Infections (STIs)
Slide 53
Slide 54
Vaginal Discharge in
Pregnancy
Substitute
With
Doxycycline
Ciprofloxacin
Slide 55
Lower Abdominal
Pain in Women
Yes
Rebound tenderness?
Guarding?
Refer
No
Overdue menses?
Abnormal vaginal bleeding?
Recent delivery/labour?
No
Yes
Yes
Suprapubic tenderness?
Vaginal discharge?
Fever?
PID risk factor?
Ciprofloxacin
500mg stat
Doxycycline
100 mg bd x 10 d
Metronidazole
400 mg tds x 7 d
Health education
Condoms
Partner treatment
HIV testing
No
Treat according to history
and other clinical findings
Refer to Handout 3.6 or Section 4.3
(page117) of the MoHSS Guidelines for
the Syndromic Management of STDs.
Unit 3: Sexually Transmitted Infections (STIs)
Improved
in 2
days?
Yes
Continue
Treatment
No
Refer
Slide 56
Salpingitis
Endometritis
Tubo-ovarian abscess
Pelvic peritonitis
Ovarian cyst
Ectopic pregnancy
Septic abortion
Appendicitis
Cystitis and pyelonephritis
Mesenteric adenitis
Slide 57
Pelvic Inflammatory
Disease (PID)
Risk Factors
Intra-uterine contraceptive
devise (IUCD)
Sexual partner with STD
HIV infection
Slide 58
Factors Suggestive
of PID
Suspect with findings on gyn
exam:
Uterine or adnexal tenderness
Cervical motion tenderness
Clinical features
Fever 38.3C
Cervical or vaginal mucopurulent
discharge
WBCs on microscopic exam of saline
preparation of vaginal fluid
Elevated ESR or CRP
Laboratory documentation of N.
gonorrhea or C. trachomatis
Negative pregnancy test
Slide 59
Pelvic Inflammatory
Disease (PID)
Treatment for GC, chlamydia,
anaerobes also covers gram
negative enteric bacteria
Oral therapy of suspected mildmoderate PID
Ciprofloxacin 500 mg po stat
Doxycycline 100 mg po bd for 10
days
Metronidazole 400 mg po tds for 7
days
Slide 60
Doxycycline po +/metronidazole po
Starts in hospital and continues
after release
Slide 61
Slide 62
Slide 63
Key Points
Slide 64